I'm looking for

Save the Date! 
The Society of Gynecologic Oncology (SGO) 2026 Winter Meeting will be held January 29-31, 2026, in Olympic Valley, CA. Save the date to celebrate 30 years of advancing science and patient care with us! Registration will open fall 2025. 
In the meantime, trainees are encouraged to submit abstracts for presentation consideration by October 17, 2025.

SUBMIT ABSTRACTS

 
 
 

If you are interested in Sponsorship or Exhibits, please reach out to industryrelations@sgo.org.

About the SGO Winter Meeting

The SGO Winter Meeting fosters collaboration among researchers at all career stages through specialized scientific sessions, insightful posters, and intimate networking events. Attendees can also enjoy exciting winter and wellness activities, blending professional growth with a relaxing retreat. The meeting’s close-knit atmosphere creates a unique environment for building connections with established leaders in gynecologic oncology.

Why Attend? 

  • Discover the latest updates in the treatment and management of gynecologic cancers. 
  • Engage in specialized scientific sessions and insightful poster presentations. 
  • Connect with colleagues and leaders in an intimate, collaborative atmosphere. 
  • Recharge with winter and wellness activities designed to balance work and retreat. 
  • Gain diverse perspectives on controversial topics in gynecologic oncology. 
  • Explore novel therapies and clinical trials shaping the future of patient care. 

 

Who Should Attend?

Gynecologic oncologists, medical oncologists, obstetricians and gynecologists, radiation oncologists, and allied health professionals involved in the care of patients who have gynecologic cancers are encouraged to attend the SGO Winter Meeting.

SGO 2026 Winter Meeting Learning Objectives:

  1. Identify and discuss the latest updates in treatment and management of gynecologic cancers.
  2. Describe various perspectives on controversial topics in the management of gynecologic cancers.
  3. Review novel therapies and clinical trials and evaluate how they may improve outcomes for patients with gynecologic cancers.

Join us as we celebrate 30 years of advancing gynecologic oncology.